INS and metabolic disease: Aberrantly high Trib3 levels are detected in insulin-resistant humans [33], [40], [41] and a population variant Trib3Q/R84 associated with predisposition to metabolic disease dominantly blocks insulin signaling in cell culture [42]–[44].